Orange Book product · Generic (ANDA)
DEXLANSOPRAZOLE
DEXLANSOPRAZOLE
Generic (ANDA)ANDA 202294TE ABRX PH HEALTH
At a glance
Jun 16, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 16, 2022
4 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
DEXLANSOPRAZOLE
Strength
30MG
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
TE code
AB
Application
ANDA 202294
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DEXLANSOPRAZOLE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
